Editors' Pick

Switching From Natalizumab to Fingolimod in Multiple Sclerosis: A French Prospective Study.

Cohen M, Maillart E, Tourbah A, De Sèze J, Vukusic S, Brassat D, Anne O, Wiertlewski S, Camu W, Courtois S, et al.

JAMA Neurol. 2014 Feb 24. Epub 1969 Dec 31. PMID: 24566807. Abstract

Editors' Pick

Body temperature is elevated and linked to fatigue in relapsing-remitting multiple sclerosis, even without heat exposure.

Sumowski JF, Leavitt VM

Arch Phys Med Rehabil. 2014 Feb 19. Epub 1969 Dec 31. PMID: 24561056. Abstract

Editors' Pick

Identifying the Start of Multiple Sclerosis Injury: A Serial DTI Study.

Ontaneda D, Sakaie K, Lin J, Wang X, Lowe MJ, Phillips MD, Fox RJ

J Neuroimaging. 2014 Nov; 24(6):569-76. Epub 2014 Feb 23. PMID: 25370339. Abstract

Papers: 14 Feb 2014 - 21 Feb 2014

Check out this week's papers from PubMed. If you are a member, please log in to recommend and comment on papers. If you are not a member, please register today and join the conversation.

Editors' Pick

Brain atrophy and disability progression in multiple sclerosis patients: a 10-year follow-up study.

Jacobsen C, Hagemeier J, Myhr K-M, Nyland H, Lode K, Bergsland N, Ramasamy DP, Dalaker TO, Larsen J P, Farbu E, et al.

J Neurol Neurosurg Psychiatry. 2014 Feb 19. PMID: 24554101. Abstract

Editors' Pick

Autologous haematopoietic stem cell transplantation for aggressive multiple sclerosis: the Swedish experience.

Burman J, Iacobaeus E, Svenningsson A, Lycke J, Gunnarsson M, Nilsson P, Vrethem M, Fredrikson S, Martin C, Sandstedt A, et al.

J Neurol Neurosurg Psychiatry. 2014 Feb 19. PMID: 24554104. Abstract

Researchers Recruiting For Study Of Blood Test That May Help To Diagnose And Monitor MS

(via the National Multiple Sclerosis Society)

Summary: Investigators are recruiting 100 individuals who are being evaluated for symptoms of MS or other neurological diseases for a study to determine the effectiveness of a new blood-based diagnostic test for MS. The study is funded by DioGenix, Inc., in partnership with the National MS Society through Fast Forward.